HEPS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HEPS is not a strong buy for a beginner, long-term investor at this moment. Despite some positive revenue growth and technical indicators showing bullish trends, the company's significant net losses, lack of strong trading signals, and no recent congress trading data make it a risky investment. The investor should consider holding off for now.
The technical indicators show a bullish trend with the MACD histogram positively expanding, RSI at 75.478 (neutral), and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). The stock is trading near its first resistance level (R1: 2.897) in pre-market, with key support at S1: 2.537.
Revenue increased by 17.8% YoY in Q4 2025, GMV grew by 10.5% YoY, and the number of orders rose by 17.6% YoY.
Gross margin dropped by 7.13% YoY in Q3
The stock has a 70% chance of only modest gains (1.02% in the next day, 2.81% in the next week) and a potential decline (-1.35%) over the next month.
In Q4 2025, revenue rose by 17.8% YoY to TRY 27.9705 billion, and GMV increased by 10.5% YoY. However, the company reported a significant net loss of TRY 3.082 billion, and gross margin dropped by 7.13% YoY in Q3 2025.
No analyst rating or price target changes provided in the data.
